A steroidogenic cell line with differentiation potential from mouse granulosa cells, transfected with Ad4BP and SV40 large T antigen genes.
Several steroidogenic cell lines of granulosa cells (GC) have been used to elucidate differentiation mechanisms of GC during folliculogenesis. These cell lines, however, are of limited usefulness since they have lost some of their differentiation potential. The transcription factor adrenal-4 binding protein (Ad4BP), also known as steroidogenic factor-1 or NR5A1, is essential for the expression of all P-450 steroidogenic enzymes. By transfection with the Ad4BP gene together with SV40 DNA, we have generated several steroidogenic cell lines. One selective clone, named 4B2, retained its steroidogenic potential and was therefore analyzed in depth. This cell line responded to 8-Br-cAMP by displaying differentiation characteristics similar to those occurring in the differentiation process of primary cultured GC, including enhanced progesterone secretion, a cell shape change from a fibroblastic to epithelioid conformation, elongated mitochondria, increased gap junction formation and inhibition of cell proliferation. Prostaglandin E2 (PGE2), an intraovarian regulator of GC, stimulated cAMP production, and this eicosanoid, like 8-Br-cAMP, induced differentiation properties with the exception of cell conformation in 4B2 cells. These results suggest that expression of Ad4BP may provide the basis for a repertoire of cAMP-sensitive differentiation properties, including morphological alterations and growth inhibition. Thus, the 4B2 cell line may serve as a tool for elucidation of differentiation mechanisms that are under the control of Ad4BP.
Kamei
Y
Y
Graduate School of Allied Health Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima Bunkyouku, Tokyo, Japan.
Aoyama
Y
Y
Fujimoto
T
T
Kenmotsu
N
N
Kishi
C
C
Koushi
M
M
Sugano
S
S
Morohashi
K
K
Kamiyama
R
R
Asakai
R
R
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D002454:Cell Differentiation; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D015232:Dinoprostone / Q000494:pharmacology; D005260:Female; D017629:Gap Junctions / Q000648:ultrastructure; D006107:Granulosa Cells / Q000166:cytology / Q000378:metabolism* / Q000648:ultrastructure; D018398:Homeodomain Proteins; D007150:Immunohistochemistry / Q000379:methods; D051379:Mice; D008928:Mitochondria / Q000648:ultrastructure; D011374:Progesterone / Q000032:analysis; D011863:Radioimmunoassay / Q000379:methods; D018160:Receptors, Cytoplasmic and Nuclear; D054339:Steroidogenic Factor 1; D013256:Steroids / Q000096:biosynthesis*; D014157:Transcription Factors / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D014162:Transfection / Q000379:methods
D000952:Antigens, Polyomavirus Transforming; D004268:DNA-Binding Proteins; D018398:Homeodomain Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D054339:Steroidogenic Factor 1; D013256:Steroids; D014157:Transcription Factors; C515058:steroidogenic factor 1, mouse; D015124:8-Bromo Cyclic Adenosine Monophosphate; D011374:Progesterone; D000242:Cyclic AMP; D015232:Dinoprostone